COVID-19 severity is due to complications from SARS-Cov-2 but the clinical course of the infection varies for individuals, emphasizing the need to better understand the disease at the molecular level. We use clinical and multiple molecular data (or views) obtained from patients with and without COVID-19 who were (or not) admitted to the intensive care unit to shed light on COVID-19 severity. Methods for jointly associating the views and separating the COVID-19 groups (i.e., one-step methods) have focused on linear relationships. The relationships between the views and COVID-19 patient groups, however, are too complex to be understood solely by linear methods. Existing nonlinear one-step methods cannot be used to identify signatures to aid in our understanding of the complexity of the disease. We propose Deep IDA (Integrative Discriminant Analysis) to address analytical challenges in our problem of interest. Deep IDA learns nonlinear projections of two or more views that maximally associate the views and separate the classes in each view, and permits feature ranking for interpretable findings. Our applications demonstrate that Deep IDA has competitive classification rates compared to other state-of-the-art methods and is able to identify molecular signatures that facilitate an understanding of COVID-19 severity.
翻译:COVID-19 严重性 COVID-19 严重性 COVID-19 是由于SARS-Cov-2 的并发症造成的,但对个人而言,感染的临床过程各有不同,强调需要在分子一级更好地理解该疾病。我们使用从曾被(或未被)收进重症护理单位的COVID-19 患者那里获得的临床和多分子数据(或意见),以说明COVID-19 严重性。将观点联合起来和分离COVID-19 群体的方法(即一步骤方法)侧重于线性关系。但是,观点与COVI-19 患者群体之间的关系过于复杂,无法仅仅通过线性方法来理解。我们现有的非线性一步骤方法无法用来确定签名,以帮助我们了解疾病的复杂性。我们建议深IDADA (Intart Discriminal 分析) 解决我们感兴趣的分析挑战。深IDADA对两种或两种或两种以上观点进行了非线性预测,这些观点最密切地将观点联系起来,将每种观点分开,并允许对每种观点进行分类,并允许为可解释结论的特征排序。我们的应用表明,深IDADADA具有竞争性程度的理解和可辨识读性特征的深度理解程度。我们所了解的分子分辨识的方法表明C-DADA具有可辨识能的分辨的分辨。